Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose versus metformin in newly diagnosed Chinese adults with type 2 diabetes
ChiCTR-TRC-08000231Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Aug 2008
- Modality
- Small Molecules, Microbiome-Derived Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of acarbose and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: HbA1c. Started Aug 2008; status: completed.
02
Drugs
acarbosemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-08000231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000231.